ライフサイエンスコーパス: neutrophil gelatinase-associated lipocalin

1 arkers (such as kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin).

2 OB-4 and keratin 20), and immune modulation (neutrophil-gelatinase-associated lipocalin).

3 ry excretion of kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin.

4 acid inhibited induction of c-fos, junb, and neutrophil gelatinase-associated lipocalin.

5 group (P = 0.0004), and was noninferior for neutrophil gelatinase-associated lipocalin [14.7 mug/L (

6 luble Tek/Tie2 receptor and in urinary MMP-9/neutrophil gelatinase-associated lipocalin activity afte

7 s no difference in concentrations of urinary neutrophil gelatinase-associated lipocalin after the 2 i

8 ant interaction between the concentration of neutrophil gelatinase-associated lipocalin, an establish

9 ression determined the prognostic utility of neutrophil gelatinase-associated lipocalin and creatinin

10 retion associated with AKI severity, and for neutrophil gelatinase-associated lipocalin and cystatin

11 These include a plasma panel (neutrophil gelatinase-associated lipocalin and cystatin

12 Neutrophil gelatinase-associated lipocalin and liver fat

13 Serum neutrophil gelatinase-associated lipocalin and serum int

14 Urinary neutrophil gelatinase-associated lipocalin and urinary k

15 rmine the prognostic utility of both urinary neutrophil gelatinase-associated lipocalin and varying c

16 jury biomarkers kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin, and doses>/=

17 The role of serum cystatin C (Scyc), neutrophil gelatinase-associated lipocalin, and interleu

18 NET components (elastase, histones, neutrophil gelatinase-associated lipocalin, and proteina

19 nt levels of high-mobility group protein B1, neutrophil gelatinase-associated lipocalin, and S100B we

20 cular cell adhesion molecule, periostin, and neutrophil gelatinase-associated lipocalin; and a two-fo

21 Serum neutrophil gelatinase-associated lipocalin at day 3 was

22 The upper quartile of urinary neutrophil gelatinase-associated lipocalin best predicte

23 Incubation of the progel B-TIMP-1-neutrophil gelatinase-associated lipocalin complex with

24 ure for serum creatinine, interleukin-6, and neutrophil gelatinase-associated lipocalin concentration

25 of known markers of renal injury, including neutrophil gelatinase-associated lipocalin, CXCL1, and C

26 ) kidney injury proteins (osteopontin [OPN], neutrophil gelatinase-associated lipocalin, cystatin C,

27 urinary levels of the iron acceptor proteins neutrophil gelatinase-associated lipocalin, hemopexin, a

28 serum levels of novel biomarkers, including neutrophil gelatinase-associated lipocalin, high-mobilit

29 Kidney injury biomarker levels (neutrophil gelatinase-associated lipocalin, IL-18, and k

30 sured the following five urinary biomarkers: neutrophil gelatinase-associated lipocalin, IL-18, kidne

31 al AKI, the highest tertiles of peak urinary neutrophil gelatinase-associated lipocalin, IL-18, KIM-1

32 valuation of novel urinary biomarkers (e.g., neutrophil gelatinase-associated lipocalin) in this pati

33 lipocalin and cystatin C) and a urine panel (neutrophil gelatinase-associated lipocalin, interleukin

34 A biomarker panel of neutrophil gelatinase-associated lipocalin, interleukin-

35 IMP-1 in a ternary complex with progel B and neutrophil gelatinase-associated lipocalin is also susce

36 mporal change markers of renal injury (urine neutrophil gelatinase-associated lipocalin, kidney injur

37 6 hours after surgery) urine interleukin 18, neutrophil gelatinase-associated lipocalin, kidney injur

38 cohort study, 5 urinary biomarkers (urinary neutrophil gelatinase-associated lipocalin, kidney injur

39 , gamma-glutamyl transpeptidase, cystatin C, neutrophil gelatinase-associated lipocalin, kidney injur

40 put <0.5 mL/kg/h for >/=12 hours) and plasma neutrophil gelatinase-associated lipocalin level higher

41 In our adjusted models, enrollment neutrophil gelatinase-associated lipocalin level was ind

42 The discriminatory power of enrollment neutrophil gelatinase-associated lipocalin level was the

43 Serum neutrophil gelatinase-associated lipocalin levels are st

44 kedly regulated the expression of NGAL/LCN2 (neutrophil gelatinase-associated lipocalin/lipocalin 2),

45 Combining both DeltaSCr-initial and neutrophil gelatinase-associated lipocalin measured 3 ho

46 al perfusion and blood flow, whereas GFR and neutrophil gelatinase-associated lipocalin, monocyte che

47 n addition, we measured renal vein levels of neutrophil gelatinase-associated lipocalin, monocyte che

48 Neutrophil gelatinase-associated lipocalin, myeloperoxid

49 (Acute Kidney Injury Neutrophil Gelatinase-Associated Lipocalin [N-GAL] Evalu

50 Human neutrophil gelatinase associated lipocalin (NGAL) was fo

51 Neutrophil gelatinase associated lipocalin (NGAL), a con

52 ns, the overall structure is most similar to neutrophil gelatinase associated lipocalin (NGAL), a pro

53 e investigated whether cystatin C (CysC) and neutrophil gelatinase-associated lipocalin (NGAL) can pr

54 MMP-9/neutrophil gelatinase-associated lipocalin (NGAL) comple

55 label-free electrochemical immunosensor for neutrophil gelatinase-associated lipocalin (NGAL) detect

56 Urinary neutrophil gelatinase-associated lipocalin (NGAL) has em

57 dy was to investigate the prognostic role of neutrophil gelatinase-associated lipocalin (NGAL) in a l

58 Neutrophil gelatinase-associated lipocalin (NGAL) is a 2

59 Previous research suggests that neutrophil gelatinase-associated lipocalin (NGAL) is a h

60 Neutrophil gelatinase-associated lipocalin (NGAL) is a n

61 Neutrophil gelatinase-associated lipocalin (NGAL) is a s

62 We tested the hypothesis that neutrophil gelatinase-associated lipocalin (NGAL) is an

63 Neutrophil gelatinase-associated lipocalin (NGAL) is an

64 rochemical immunosensor for the detection of neutrophil gelatinase-associated lipocalin (NGAL) is dev

65 Neutrophil gelatinase-associated lipocalin (NGAL) is exp

66 udy was to determine the association between neutrophil gelatinase-associated lipocalin (NGAL) levels

67 Neutrophil gelatinase-associated lipocalin (NGAL) was re

68 metalloproteinase (MMP)-3, MMP-8, MMP-9, and neutrophil gelatinase-associated lipocalin (NGAL) were f

69 bronectin, interleukin-8 (IL-8), biotin, and neutrophil gelatinase-associated lipocalin (NGAL) were t

70 tly, the secreted protein 24p3 (lipocalin-2, neutrophil gelatinase-associated lipocalin (NGAL)), whic

71 ntrasted the results with those obtained for neutrophil gelatinase-associated lipocalin (NGAL), a com

72 We explored the expression of neutrophil gelatinase-associated lipocalin (NGAL), a mar

73 t HGF stimulates epithelial cells to express neutrophil gelatinase-associated lipocalin (Ngal), a mem

74 med to assess the prognostic value of plasma neutrophil gelatinase-associated lipocalin (NGAL), a nov

75 Neutrophil gelatinase-associated lipocalin (Ngal), also

76 ti-DNA antibodies induced high expression of neutrophil gelatinase-associated lipocalin (NGAL), an ir

77 (AAG), transferrin (TF), ceruloplasmin (CP), neutrophil gelatinase-associated lipocalin (NGAL), and m

78 ized genes was further characterized, namely neutrophil gelatinase-associated lipocalin (NGAL), becau

79 dney transplant patients to evaluate urinary neutrophil gelatinase-associated lipocalin (NGAL), IL-18

80 Median values for neutrophil gelatinase-associated lipocalin (NGAL), inter

81 Urine neutrophil gelatinase-associated lipocalin (NGAL), kidne

82 ured urinary concentrations of microalbumin, neutrophil gelatinase-associated lipocalin (NGAL), kidne

83 s compared with urinary interleukin (IL)-18, neutrophil gelatinase-associated lipocalin (NGAL), kidne

84 This study measured levels of neutrophil gelatinase-associated lipocalin (NGAL), kidne

85 ing of these novel AKI biomarkers, including neutrophil gelatinase-associated lipocalin (NGAL), kidne

86 postoperative measures of urine IL-18, urine neutrophil gelatinase-associated lipocalin (NGAL), or pl

87 postoperative measures of urine IL-18, urine neutrophil gelatinase-associated lipocalin (NGAL), or pl

88 oparticle-based immunoassay for detection of neutrophil gelatinase-associated lipocalin (NGAL), which

89 ntibodies specific for human MMP-9 and human neutrophil gelatinase-associated lipocalin (NGAL).

90 reduced for neutrophil collagenase (NC) and neutrophil gelatinase-associated lipocalin (NGAL).

91 being a complex of gelatinase B (MMP-9) and neutrophil gelatinase-associated lipocalin (NGAL).

92 y isolated from human neutrophils and termed neutrophil gelatinase-associated lipocalin (NGAL).

93 eatinine ratio (ACR), and urinary and plasma neutrophil gelatinase-associated lipocalin (NGAL); each

94 The neutrophil gelatinase-associated lipocalin (NGAL, also k

95 dentified as a neutrophil granule component, neutrophil gelatinase-associated lipocalin (NGAL; also c

96 Lipocalin 2 (Lcn2; 24p3; neutrophil gelatinase-associated lipocalin [NGAL]) is an

97 and in combination) of 4 urinary biomarkers (neutrophil gelatinase-associated lipocalin [NGAL], inter

98 damage (kidney injury molecule-1, KIM-1 and neutrophil gelatinase-associated lipocalin, NGAL), kidne

99 pe plasminogen activator receptor, suPAR and neutrophil gelatinase-associated lipocalin, NGAL.

100 siderocalin (SCN; also known as lipocalin 2, neutrophil gelatinase-associated lipocalin/NGAL, or 24p3

101 Primary outcome was noninferiority for urine neutrophil gelatinase-associated lipocalin on the day af

102 siderocalin (SCN; also known as lipocalin-2, neutrophil gelatinase-associated lipocalin, or 24p3) int

103 rkers tested, the optimal 3-marker panel was neutrophil gelatinase-associated lipocalin, protein C, a

104 Urine neutrophil gelatinase-associated lipocalin remained inde

105 ll as pimelylcarnitine linked with levels of neutrophil gelatinase-associated lipocalin representing

106 the mouse and human homologues 24p3/lcn2 and neutrophil gelatinase-associated lipocalin, show great f

107 redox-active iron, interleukin (IL)-18, and neutrophil gelatinase-associated lipocalin to predict PN

108 nding protein, redox-active iron, IL-18, and neutrophil gelatinase-associated lipocalin to predict vi

109 on of apoptotic pathways, and no increase in neutrophil gelatinase-associated lipocalin to suggest tu

110 Renal vein neutrophil gelatinase-associated lipocalin, tumor necros

111 observed glycoproteins (e.g., cadherin 5 and neutrophil gelatinase-associated lipocalin) typically ci

112 tudies evaluating the cut-off level of urine neutrophil gelatinase-associated lipocalin (uNGAL) for d

113 Urinary neutrophil gelatinase-associated lipocalin (uNGAL) has b

114 Urine neutrophil gelatinase-associated lipocalin (uNGAL) has s

115 ysC]) with a tubular damage biomarker (urine neutrophil gelatinase-associated lipocalin [uNGAL]), for

116 Urinary neutrophil gelatinase-associated lipocalin was measured

117 were elevated in intrinsic AKI, but urinary neutrophil gelatinase-associated lipocalin was most usef

118 Urine neutrophil gelatinase-associated lipocalin was the most

119 e presence of recombinant wild-type sequence neutrophil gelatinase-associated lipocalin, wild-type cy

120 Combining urinary neutrophil gelatinase-associated lipocalin with a novel